Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Structure-Activity Relationships and Drug Design

Structure-Activity Relationships and Drug Design

Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence its...

Drug Discovery: Overview

Drug Discovery: Overview

Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...

Protein Organization

Protein Organization

Proteins are polymers of amino acid residues. They are versatile and responsible for different cellular functions, including DNA replication, molecular transport, catalysis, and structural support. Proteins have a hierarchical structure comprising at least three levels of organization: primary, secondary, and tertiary structure. Some large proteins have a quaternary structure where individual protein subunits are linked together.
The primary structure of a protein is its amino acid sequence.

Protein-protein Interfaces

Protein-protein Interfaces

Many proteins form complexes to carry out their functions, making protein-protein interactions (PPIs) essential for an organism's survival. Most PPIs are stabilized by numerous weak noncovalent chemical forces. The physical shape of the interfaces determines the way two proteins interact. Many globular proteins have closely-matching shapes on their surfaces, which form a large number of weak bonds. Additionally, many PPIs occur between two helices or between a surface cleft and a polypeptide...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

The New Paradigm in Pharma R&D.

ACS medicinal chemistry letters·2025

Same author

Identification of Small-Molecule Inhibitors that Block the GTP-Binding Pocket of K-Ras and Other Members of the Ras Superfamily of Small GTPases.

Molecular cancer therapeutics·2025

Same author

Uncompetitive, adduct-forming SARM1 inhibitors are neuroprotective in preclinical models of nerve injury and disease.

Neuron·2022

Same author

Chemistry, information and Frank: a tribute to Frank Brown.

Journal of computer-aided molecular design·2018

Same author

An improved set of mndo parameters for sulfur.

Journal of computational chemistry·2017

Same author

Group Additivity in Ligand Binding Affinity: An Alternative Approach to Ligand Efficiency.

Journal of chemical information and modeling·2017

Search research articles

Related Experiment Video

Updated: May 8, 2026

Incorporating Target Protein Structure Flexibility and Dynamics in Computational Drug Discovery Using Ensemble-Based Docking Analysis

Incorporating Target Protein Structure Flexibility and Dynamics in Computational Drug Discovery Using Ensemble-Based Docking Analysis

Published on: June 20, 2025

Impact of computational structure-based methods on drug discovery.

Charles H Reynolds¹

¹Gfree Bio, LLC, 3805 Old Easton Road, Doylestown, Pennsylvania 18902. creynolds@gfreebio.com.

Current Pharmaceutical Design

|August 17, 2013

Summary

Structure-based drug design leverages structural biology and computational power to accelerate the discovery of new medicines. This approach has significantly impacted modern drug development, leading to groundbreaking therapeutic innovations.

More Related Videos

Nano-Differential Scanning Fluorimetry for Screening in Fragment-based Lead Discovery

Nano-Differential Scanning Fluorimetry for Screening in Fragment-based Lead Discovery

Published on: May 16, 2021

Related Experiment Videos

Last Updated: May 8, 2026

Incorporating Target Protein Structure Flexibility and Dynamics in Computational Drug Discovery Using Ensemble-Based Docking Analysis

Incorporating Target Protein Structure Flexibility and Dynamics in Computational Drug Discovery Using Ensemble-Based Docking Analysis

Published on: June 20, 2025

Nano-Differential Scanning Fluorimetry for Screening in Fragment-based Lead Discovery

Nano-Differential Scanning Fluorimetry for Screening in Fragment-based Lead Discovery

Published on: May 16, 2021

Area of Science:

Biochemistry
Computational Chemistry
Pharmacology

Background:

Structure-based drug design (SBDD) is a critical tool in modern drug discovery.
Advances in structural biology, computational algorithms, and computing power have driven SBDD's emergence.
Numerous groundbreaking drugs have resulted from SBDD methodologies.

Purpose of the Study:

To highlight the evolution of computational structure-based drug design.
To demonstrate the impact of SBDD on drug discovery.

Main Methods:

Review of advancements in structural biology techniques.
Analysis of new computational algorithms for modeling protein-ligand interactions.
Examination of the role of increased computational power.

Main Results:

Exponential growth in protein crystal structure availability.
Development of sophisticated computational modeling approaches.
Significant contributions of computer modeling and simulation to drug discovery.

Conclusions:

Computational structure-based design is indispensable in modern drug discovery.
The methodology has evolved significantly over the past 30 years.
SBDD continues to drive the development of innovative therapeutics.